Umbilical cord cell infusion aims to prevent painful mouth sores in transplant patients

NCT ID NCT07400328

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether a one-time infusion of amimestrocel, made from donated umbilical cord cells, can prevent severe mouth and gut sores in people receiving a stem cell transplant. About 22 adults will get the infusion before their transplant, and researchers will monitor for sores, pain, and side effects for up to 100 days. The goal is to see if this cell therapy reduces the rate of severe oral mucositis, a common and painful complication of transplant conditioning.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
amimestrocel (umbilical cord mesenchymal stem cells)
What this could lead to
If it works, this could offer a way to prevent painful mouth and gut sores in patients undergoing stem cell transplants, reducing pain and infection risk.
What could go wrong
This is a small, early-phase study with only 22 participants, so results may not apply to everyone. The treatment may not reduce severe mouth sores, and there could be unknown side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL MUCOSITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • First Affiliated Hospital of Soochow University

    RECRUITING

    Suzhu, Jiangsu, 215006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.